Kentaro Sumida

Tumor‐infiltrating IL‐17‐producing γδ T cells support the progression of tumor by promoting angiogenesis

Daiko Wakita, Kentaro Sumida, Yoichiro Iwakura et al. · European Journal of Immunology · 2010 · 234 citations

Life Sciences, Immunology, Oncology +17

Anti‐<scp>IL</scp>‐6 receptor m<scp>A</scp>b eliminates myeloid‐derived suppressor cells and inhibits tumor growth by enhancing <scp>T</scp>‐cell responses

Kentaro Sumida, Daiko Wakita, Yoshinori Narita et al. · European Journal of Immunology · 2012 · 125 citations · Full text

Life Sciences, Immunology, Oncology +17

IL-6 down-regulates HLA class II expression and IL-12 production of human dendritic cells to impair activation of antigen-specific CD4+ T cells

Yosuke Ohno, Hidemitsu Kitamura, Norihiko Takahashi et al. · Cancer Immunology Immunotherapy · 2016 · 112 citations · Full text

Life Sciences, Cell Biology, Immunology +16

Lack of interleukin‐6 in the tumor microenvironment augments type‐1 immunity and increases the efficacy of cancer immunotherapy

Yosuke Ohno, Yujiro Toyoshima, Hideaki Yurino et al. · Cancer Science · 2017 · 85 citations · Full text

Medicine, Immunology, Oncology +17

The Key Role of IL-6–Arginase Cascade for Inducing Dendritic Cell–Dependent CD4+ T Cell Dysfunction in Tumor-Bearing Mice

Yoshinori Narita, Hidemitsu Kitamura, Daiko Wakita et al. · The Journal of Immunology · 2012 · 78 citations

Life Sciences, Immunology, Oncology +17